CCRF-CEM CDX Model 

Synonyms: CEM

The CCRF-CEM cell line originates from human acute T cell lymphoblastic leukemia (T-ALL), a subtype of acute lymphoblastic leukemia that arises from T cell precursors. CCRF-CEM provides a valuable in vitro and in vivo model for understanding the biology, pathogenesis, and therapeutic responses of T-ALL. Exhibiting key molecular characteristics and genetic features of T-ALL, the CCRF-CEM cell line serves as a representative model for preclinical investigations related to this aggressive leukemia. Its behavior closely mimics the rapid proliferative nature of T-ALL, along with its interactions with the bone marrow microenvironment and potential for systemic dissemination. Researchers frequently utilize CCRF-CEM to gain deeper insights into T-ALL pathogenesis, the leukemia-stroma interactions, and to test and develop new therapeutic regimens, particularly those related to targeted and chemotherapeutic interventions.

Model Details

Cancer Location: Intravenous
Cancer Type: Acute T Cell Lymphoblastic Leukemia
Model Name: CCRF-CEM
Mouse Strain: NSG, CB.17 SCID

CCRF-CEM Growth Curves

Growth of subcutaneous CCRF-CEM in NSG mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content